Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Oncotarget
|
August 4, 2016
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
Sandeep Rajput, Nimmish Khera, Zhanfang Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2018
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
Meenakshi Anurag, Nindo Punturi, Jeremy Hoog, et al.
Journal of Health Care for the Poor and Underserved
|
June 15, 2026
"It's Not a One-Size-Fits-All": Patient Perspectives on Contingency Management and Community Reinforcement Approach for Methamphetamine Use Disorder in Permanent Supportive Housing
Sarah Leyde, Carson Bell, Christina Harris, et al.
JAMA Network Open
|
August 15, 2025
Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting
Richard C Waters, Jeremy Hoog, Carson Bell, et al.
Journal of the National Cancer Institute
|
October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)
Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 31, 2018
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER<sup>+</sup> breast cancer
Kevin Shee, Amanda Jiang, Frederick S Varn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
Cynthia X Ma, Cesar Sanchez, Feng Gao, et al.
The Journal of Experimental Medicine
|
November 19, 2003
Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells
Keiko Fujikawa, Ana V Miletic, Frederick W Alt, et al.
Oncotarget
|
December 22, 2017
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent
Bernadette V Marquez-Nostra, Supum Lee, Richard Laforest, et al.
Breast Cancer Research and Treatment
|
June 15, 2017
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
Rodrigo Goncalves, Katherine DeSchryver, Cynthia Ma, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Oncotarget
|
August 4, 2016
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
Sandeep Rajput, Nimmish Khera, Zhanfang Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 26, 2018
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers
Meenakshi Anurag, Nindo Punturi, Jeremy Hoog, et al.
Journal of Health Care for the Poor and Underserved
|
June 15, 2026
"It's Not a One-Size-Fits-All": Patient Perspectives on Contingency Management and Community Reinforcement Approach for Methamphetamine Use Disorder in Permanent Supportive Housing
Sarah Leyde, Carson Bell, Christina Harris, et al.
JAMA Network Open
|
August 15, 2025
Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting
Richard C Waters, Jeremy Hoog, Carson Bell, et al.
Journal of the National Cancer Institute
|
October 31, 2019
Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance)
Meenakshi Anurag, Mayanne Zhu, Chen Huang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 31, 2018
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER<sup>+</sup> breast cancer
Kevin Shee, Amanda Jiang, Frederick S Varn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 20, 2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer
Cynthia X Ma, Cesar Sanchez, Feng Gao, et al.
The Journal of Experimental Medicine
|
November 19, 2003
Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells
Keiko Fujikawa, Ana V Miletic, Frederick W Alt, et al.
Oncotarget
|
December 22, 2017
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent
Bernadette V Marquez-Nostra, Supum Lee, Richard Laforest, et al.
Breast Cancer Research and Treatment
|
June 15, 2017
Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer
Rodrigo Goncalves, Katherine DeSchryver, Cynthia Ma, et al.
Page
of 5